Harry Thomasian Jr. - 16 May 2022 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
Chief Financial Officer
Signature
/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact
Issuer symbol
PGEN
Transactions as of
16 May 2022
Transactions value $
-$3,480
Form type
4
Filing time
18 May 2022, 18:51:57 UTC
Previous filing
22 Mar 2022
Next filing
24 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Options Exercise +8.11K +30.6% 34.6K 16 May 2022 Direct F1
transaction PGEN Common Stock Sale -$3.48K -2.72K -7.86% $1.28 31.9K 17 May 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Options Exercise $0 -8.11K -100% $0.00* 0 16 May 2022 Common Stock 8.11K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2 This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
F3 The RSUs were granted on March 18, 2022 and have vested in full.